Cholamandalam Financial Holdings Ltd.

NSE: CHOLAHLDNG
NIFTY500
Analyst consensus:Strongly constructive· 3 analysts
₹1,648.40-18.6%1Y
Last updated 03:04:57 IST· Public market feed (~15 min delay during market hours)

Cholamandalam Financial Holdings Ltd.: A 30-second snapshot

Cholamandalam Financial Holdings (₹1,658) is the listed holding company for Cholamandalam Investment and Finance (vehicle and home loans NBFC) and Chola MS General Insurance. Trailing PE of 12.75 is the lowest among the six Banking-sector peers tracked, while ROE of 18.04% is the highest in the peer group. The stock is 25.65% below its 52-week high and has declined 7.04% over the past 12 months, trading below its 200-DMA of ₹1,769.84.

P/E

12.8

Forward P/E

8.2

ROE

+18.0%

Debt / Equity

621.27

Profit Margin

+9.7%

Div. Yield

+0.1%

5Y ROE > 15%

3/5

5Y FCF > 0

0/5

Quality

55/100

Recent context

  • ·Q4 FY26 results (reported May 2026) showed consolidated net profit of ₹6.87 billion, with the lending segment reporting strong revenue and profit growth while the general insurance segment was impacted by higher claims — a segment-level divergence within the holding structure.
  • ·A CFO change at the holding company was announced in May 2026; management transitions at the corporate centre level of a multi-subsidiary structure can affect capital allocation and investor communication continuity.
  • ·The board announced consideration of a dividend for FY26; the trailing dividend yield is 0.08%, making this a capital-appreciation rather than income-oriented holding by current payout levels.

Strengths

  • +Highest ROE in the peer group at 18.04%, ahead of BAJFINANCE (17.91%), HDFCBANK (13.82%), BAJAJFINSV (14.6%), and AXISBANK (13.15%) — suggesting the subsidiaries are generating returns above sector median.
  • +Lowest trailing PE of 12.75 across the six tracked peers, where the next closest is AXISBANK at 14.73 and BAJFINANCE at 29.85 — the holding company structure trades at a meaningful discount to pure-play NBFC peers.
  • +5-year revenue CAGR of 18.2% reflects consistent top-line expansion at the subsidiary level, indicating franchise growth in vehicle finance and insurance over the measurement period.
  • +Forward PE of 8.25 versus trailing PE of 12.75 implies analyst estimates embed meaningful earnings expansion — the gap between trailing and forward multiples is among the widest in the peer set.

Weaknesses

  • Free cash flow has been negative in all 5 recorded years at the consolidated holding level; a rising debt trend compounds this, making the parent entity dependent on subsidiary dividend upstreams rather than independent cash generation.
  • Debt-to-equity of 621.27 reflects the financial services leverage model but is many multiples above non-financial peers; any deterioration in subsidiary asset quality or regulatory capital requirements could constrain upstream cash flows.
  • Stock is 25.65% below its 52-week high and has underperformed on both a 1-year (-7.04%) and 3-month (-6.53%) basis, with price sitting below the 200-DMA (₹1,769.84) — a persistent technical overhang relative to the medium-term trend.
  • ROE has exceeded 15% in only 3 of the tracked years (consistency score 56/100), and profit margin of 9.69% with a 5-year earnings CAGR of 12% indicates moderate — not exceptional — earnings durability at the current leverage level.

Open questions

  • ?Does the forward PE compression from 12.75 to 8.25 reflect a genuine step-change in subsidiary earnings power, or does it assume a normalisation of insurance claims that may not materialise if claims remain elevated?
  • ?How dependent is the holding company's debt serviceability on regular dividend upstream from Cholamandalam Investment and Finance, and what regulatory or RBI capital buffer changes could interrupt that flow?
  • ?Does the 25.65% drawdown from the 52-week high reflect a re-rating of the holding-company discount, a broader NBFC sector derating, or stock-specific concerns — and which of these is the more durable factor?
  • ?How has the ROE trajectory at Cholamandalam Investment and Finance evolved through credit cycles, and does the current 18.04% consolidated ROE incorporate the insurance drag from higher claims in a way that is sustainable?

Peer comparison: Banking

Ranks 3 of 6 on quality
SymbolNameP/EROEQuality
CHOLAHLDNGCholamandalam Financial Holdings Ltd.You're viewing12.8+18.0%52
Industry avgacross 5 peers31.7+14.2%39
AXISBANKAxis Bank Ltd.14.7+13.2%53
BAJFINANCEBajaj Finance Ltd.29.9+17.9%53
HDFCBANKHDFC Bank Ltd.17.1+13.8%47
BAJAJFINSVBajaj Finserv Ltd.28.3+14.6%23
HDFCLIFEHDFC Life Insurance Company Ltd.68.5+11.3%20

Technical state

Current price

₹1,658.00

SMA 50

₹1,562.76

SMA 200

₹1,769.84

RSI (14)

52.7 (neutral)

From 52w high

-25.6%

1Y return

-7.0%

3M return

-6.5%

50-DMA

Above

200-DMA

Below

Algorithmic support levels

₹1,587.00
₹1,519.90
₹1,305.00

Algorithmic resistance levels

₹1,658.90
₹1,675.90
₹1,749.50

Risk flags

  • high
    Debt-to-equity of 621.27 is structurally elevated even for a financial holding company. More critically, free cash flow has been negative in all 5 recorded years (fcfPositiveYears = 0) alongside a rising debt trend, indicating the consolidated entity has consistently consumed cash at the holding level.
  • high
    FCF positive in 0 of 5 available years, with debt trend rising. The holding company structure means dividends upstreamed from operating subsidiaries (Cholamandalam Investment and Finance, Chola MS General Insurance) are the primary cash inflow; any stress at the subsidiary level would directly constrain the parent.
  • medium
    Stock is 25.65% below its 52-week high and has declined 7.04% over the past 12 months. Price remains below the 200-DMA (₹1,769.84) despite a recent recovery above the 50-DMA (₹1,562.76). Current price of ₹1,658 sits immediately at the first resistance cluster of ₹1,658.9–₹1,675.9.
  • medium
    ROE has exceeded 15% in only 3 of the available years (roeYearsAbove15 = 3), and the consistency score is 56 out of 100. Profit margin of 9.69% and 5-year earnings CAGR of 12% are moderate relative to the leverage the balance sheet carries.
  • low
    News sample is limited to 6 articles. A CFO change was announced (May 2026), which is a leadership transition worth monitoring at the holding entity level. Insurance segment was flagged for higher claims impact in the most recent earnings coverage.

Cross-section contradictions

  • Forward PE of 8.25 versus trailing PE of 12.75 implies a near-40% step-up in earnings expected by the market, yet the 5-year earnings CAGR has been 12% and FCF has been negative every recorded year — the forward compression assumption depends on a structural earnings acceleration not yet visible in the cash flow record.
  • News sentiment is uniformly non-negative (3 positive, 3 neutral, 0 negative) and Q4 FY26 PAT was reported, yet the stock is down 7.04% over 12 months and 25.65% from its 52-week high, suggesting market pricing reflects concerns not captured in the near-term earnings headlines.

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.

Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST

AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 17 May 2026 · rotates through NIFTY 500 every ~5 days